Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Childhood trauma survivors: new study probes hidden dissociative disorder rates

NCT ID NCT06330467

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at how often dissociative identity disorder (DID) occurs in adults who experienced childhood trauma and have borderline personality disorder, functional dissociative crises, or early psychosis. Researchers will use interviews and questionnaires with 350 participants to find links between trauma types and dissociative symptoms. The goal is to better understand these conditions, not to test a treatment.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 350 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jun 2024

Expected to finish

Aug 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

I - Inclusion Criteria: I-1: For all groups: * Male or female * Age \> or = 18 * Enrolled in or benefiting from a social security scheme * Patient fluent in French * Patient willing to undergo a psychological evaluation between 1h30 and 3h30 * Patient with a known history of psychotrauma in childhood before the age of 18 (sexual abuse, mistreatment, school harassment, natural disasters, attacks, etc.). * Patient having received and understood complete information on the organization of the research and having given written free and informed consent prior to participation in the study. I-2 : Patients in the borderline group * Patients with main diagnosis of emotionally labile personality * Patients with at least one psychiatric hospitalization in the last 3 years I-3 : Patients in the early psychosis group Patient with a diagnosis of mental state at risk of psychosis according to the criteria defined by CAARMS (Comprehensive Assessment of At Risk Mental State) OR Patients diagnosed with a first psychotic episode on an outpatient basis or following a hospital stay I-4 : Patients in the functional dissociative crises group Patients diagnosed with functional dissociative crises by a specialized epileptologist II- Non-inclusion criteria * Impairment of the subject making it difficult or not impossible to participate in the trial or to understand the information provided to him/her * Patients with specific difficulties in understanding SCID-D questions * Psychiatric condition requiring hospitalization * Patients with symptoms of recent toxic consumption (alcohol, cannabis, other ...) disrupting assessment responses * Patient taking part in a pharmacological study involving a pro-dissociative molecule of the psychedelic type * Pregnant, parturient or nursing mothers * Person deprived of liberty by judicial or administrative decision * Person in a life-threatening emergency * An adult under legal protection (guardianship, curatorship, safeguard of justice) * Person unable to give consent and not subject to a legal protection measure

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Borderline personality disorder are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    3 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • CHRU Nancy - Neurology department

    RECRUITING

    Nancy, France

  • Centre Psychothérapique de Nancy - CLIP

    NOT_YET_RECRUITING

    Nancy, France

  • Centre Psychothérapique de Nancy - CMP Jacquard et Des Près

    RECRUITING

    Nancy, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.